Botanix Investor Centre
Botanix is an ASX-listed company (ASX:BOT), in a prime position for growth and to return value for shareholders. With deep expertise in dermatology and pharmaceutical product commercialisation, we are on track to disrupt some of the most lucrative global healthcare markets.
ASX: BOT | Share price
Change
ASX Releases
Analyst Reports
April 6, 2023
Euroz Hartleys – BOT: Successful Mid-Cycle Review
Euroz Hartleys – BOT: Successful Mid-Cycle Review
Aug 9, 2021
Feb 4, 2021
Mar 16, 2020
Feb 3, 2020
Oct 24, 2019
Oct 23, 2019
June 18, 2019
Nov 21, 2018
Nov 21, 2018
July 20, 2018
January 30, 2018
November 3, 2017
August 21, 2017
August 17, 2017
May 9, 2017
April 21, 2017
April 6, 2017
March 22, 2017
Corporate governance
Investor Services
Presentations
9 March 2023
31 January 2023
9 January 2023
23 November 2022
18 November 2022
13 October 2022
27 July 2022
12 July 2022
16 May 2022
14 March 2022
25 February 2022
08 December 2021
26 October 2021
1 September 2021
5 May 2021
4 May 2021
19 February 2021
23 November 2020
September 8, 2020
January 13, 2020
December 9, 2019
November 21, 2019
October 28, 2019
October 23, 2019
September 17, 2019
September 13, 2019
June 24, 2019
January 31, 2019
December 14, 2018
December 5, 2018
November 15, 2018
October 19, 2018
September 13, 2018
August 13, 2018
July 2, 2018
April 9, 2018
February 15, 2018
January 22, 2018
January 7, 2018
November 13, 2017
July 11, 2017
May 4, 2017
April 5, 2017
March 22, 2017
